{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:59:46Z","timestamp":1783393186052,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcv.2017.09.011","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T14:01:28Z","timestamp":1506175288000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact"],"prefix":"10.1016","volume":"96","author":[{"given":"Martina","family":"Vitrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Iossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia Clara","family":"Pafundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Molaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Parrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ragone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Maiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Durante-Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2017.09.011_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jcv.2017.09.011_bib0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4254\/wjh.v7.i3.600","article-title":"Occult hepatitis B virus infection and blood transfusion","volume":"7","author":"Seo","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0015","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2217\/17460794.2.5.451","article-title":"Molecular diagnosis of occult HCV and HBV infections","volume":"2","author":"Michalak","year":"2007","journal-title":"Future Virol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00281-012-0327-7","article-title":"Occult HBV infection","volume":"35","author":"Raimondo","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2004.12.015","article-title":"New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA","volume":"42","author":"Zoulim","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0609.2001.067001045.x","article-title":"Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies","volume":"67","author":"Kawatani","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0045","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00007890-199809150-00012","article-title":"Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc","volume":"66","author":"Dhedin","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2017.09.011_bib0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0168-8278(98)80017-2","article-title":"Reactivation of hepatitis B in a long-term anti-HBs positive patient with AIDS following lamivudine withdrawal","volume":"29","author":"Altfeld","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0055","first-page":"126","article-title":"Hepatitis B virus reactivation after kidney transplantation and new onset lymphoma","volume":"5","author":"Larghi","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0060","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/lt.20858","article-title":"Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier","volume":"12","author":"Zollner","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.jcv.2017.09.011_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/bmt.2010.70","article-title":"Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT","volume":"46","author":"Vigano","year":"2011","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2017.09.011_bib0070","first-page":"15","article-title":"The clinical significance of occult B infection","volume":"27","author":"Squadrito","year":"2014","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0075","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.3748\/wjg.v20.i20.5951","article-title":"Occult hepatitis B virus and hepatocellular carcinoma","volume":"20","author":"Pollicino","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0080","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.09.011_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrgastro.2013.216","article-title":"Management of patients with hepatitis B who require immunosuppressive therapy","volume":"11","author":"Hwang","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.trre.2011.02.001","article-title":"Hepatitis B virus and renal transplantation","volume":"25","author":"Kalia","year":"2011","journal-title":"Transplant. Rev. (Orlando, Fla.)"},{"key":"10.1016\/j.jcv.2017.09.011_bib0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/tid.12065","article-title":"Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers","volume":"15","author":"Chen","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2017.09.011_bib0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4174\/astr.2014.86.5.256","article-title":"High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients","volume":"86","author":"Kim","year":"2014","journal-title":"Ann. Surg. Treat. Res."},{"key":"10.1016\/j.jcv.2017.09.011_bib0105","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.transproceed.2013.01.088","article-title":"Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy","volume":"45","author":"Kim","year":"2013","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.jcv.2017.09.011_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.jcv.2017.09.011_bib0115","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"ISHLT Guidelines for the care of heart transplant recipients","volume":"29","author":"International Society of Heart","year":"2010","journal-title":"J. Heart Lung Transpl."},{"issue":"March (Suppl. 4)","key":"10.1016\/j.jcv.2017.09.011_bib0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ajt.12108","article-title":"AST infectious diseases community of practice. viral hepatitis in solid organ transplantation","volume":"13","author":"Levitsky","year":"2013","journal-title":"Am. J. Transpl."},{"issue":"January (1)","key":"10.1016\/j.jcv.2017.09.011_bib0125","first-page":"1","article-title":"APASL Clinical Practice Guidelines on the management of hepatitis B; a 2015 update","volume":"10","author":"Asian Pacific Association for the Study of the Liver","year":"2016","journal-title":"Hepatol. Int."},{"issue":"March (8)","key":"10.1016\/j.jcv.2017.09.011_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4254\/wjh.v8.i8.385","article-title":"Management of hepatitis B reactivation in immunosuppressed patients: an update on current recommendations","volume":"8","author":"Bessone","year":"2016","journal-title":"World J. Hepatol."},{"issue":"November (1)","key":"10.1016\/j.jcv.2017.09.011_bib0135","first-page":"261","article-title":"AASLD Guidelines for treatment of chronic hepatitis B","volume":"63","author":"American Association for the Study of Liver Diseases","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.09.011_bib0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J. Heart Lung Transpl."},{"key":"10.1016\/j.jcv.2017.09.011_bib0150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/01.tp.0000176941.21438.95","article-title":"Heart transplantation in patients with chronic hepatitis B: clinical evolution, molecular analysis, and effect of treatment","volume":"80","author":"Zampino","year":"2005","journal-title":"Transplantation"},{"issue":"September (9)","key":"10.1016\/j.jcv.2017.09.011_bib0155","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1572-0241.2002.05998.x","article-title":"Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission","volume":"97","author":"Zampino","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0160","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.TP.0000163468.80223.74","article-title":"Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation","volume":"79","author":"Kn\u00f6ll","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2017.09.011_bib0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcv.2004.10.006","article-title":"HBV reactivation after kidney transplantation","volume":"32","author":"Berger","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/tid.12065","article-title":"Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers","volume":"15","author":"Chen","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2017.09.011_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4254\/wjh.v7.i2.189","article-title":"Antiviral treatment for chronic hepatitis B in renal transplant patient","volume":"7","author":"Ridruejo","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cld.481","article-title":"Histologic and noninvasive estimates of liver fibrosis","volume":"6","author":"Bedossa","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jcv.2017.09.011_bib0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.09.011_bib0190","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid organ transplantation from hepatitis B virus-positive donor: consensus guidelines for recipient management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am. J. Transpl."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217302743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217302743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T05:25:04Z","timestamp":1535347504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653217302743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"alternative-id":["S1386653217302743"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2017.09.011","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2017.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}